Cargando…
Neutralizing hepatitis B
Despite an effective vaccine, hepatitis B virus (HBV) remains a major public health threat since chronic infection leads to liver disease and cancer. Hehle et al. (https://doi.org/10.1084/jem.20200840) discovered human-derived antibodies that potently neutralize the virus. Will this help a cure?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Rockefeller University Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537398/ https://www.ncbi.nlm.nih.gov/pubmed/32790869 http://dx.doi.org/10.1084/jem.20201261 |
| _version_ | 1783590666605953024 |
|---|---|
| author | Robbiani, Davide F. |
| author_facet | Robbiani, Davide F. |
| author_sort | Robbiani, Davide F. |
| collection | PubMed |
| description | Despite an effective vaccine, hepatitis B virus (HBV) remains a major public health threat since chronic infection leads to liver disease and cancer. Hehle et al. (https://doi.org/10.1084/jem.20200840) discovered human-derived antibodies that potently neutralize the virus. Will this help a cure? |
| format | Online Article Text |
| id | pubmed-7537398 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Rockefeller University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75373982021-04-05 Neutralizing hepatitis B Robbiani, Davide F. J Exp Med Insights Despite an effective vaccine, hepatitis B virus (HBV) remains a major public health threat since chronic infection leads to liver disease and cancer. Hehle et al. (https://doi.org/10.1084/jem.20200840) discovered human-derived antibodies that potently neutralize the virus. Will this help a cure? Rockefeller University Press 2020-08-13 /pmc/articles/PMC7537398/ /pubmed/32790869 http://dx.doi.org/10.1084/jem.20201261 Text en © 2020 Robbiani http://www.rupress.org/terms/https://creativecommons.org/licenses/by-nc-sa/4.0/This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/). |
| spellingShingle | Insights Robbiani, Davide F. Neutralizing hepatitis B |
| title | Neutralizing hepatitis B |
| title_full | Neutralizing hepatitis B |
| title_fullStr | Neutralizing hepatitis B |
| title_full_unstemmed | Neutralizing hepatitis B |
| title_short | Neutralizing hepatitis B |
| title_sort | neutralizing hepatitis b |
| topic | Insights |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537398/ https://www.ncbi.nlm.nih.gov/pubmed/32790869 http://dx.doi.org/10.1084/jem.20201261 |
| work_keys_str_mv | AT robbianidavidef neutralizinghepatitisb |